BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6215440)

  • 1. Lithium ratio and maintenance treatment response.
    Kocsis JH; Kantor JS; Lieberman KW; Stokes PE
    J Affect Disord; 1982 Sep; 4(3):213-8. PubMed ID: 6215440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The red blood cell/plasma lithium ratio: marker of biological heterogeneity within bipolar affective illness?
    Rihmer Z; Arató M; Szentistványi I; Bánki CM
    Psychiatry Res; 1982 Apr; 6(2):197-201. PubMed ID: 6806837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell/plasma lithium ratio in manic-depressive, schizoaffective, and schizophrenic patients.
    Rihmer Z; Arató M; Szentistványi I; Bánki CM
    Psychiatr Clin (Basel); 1983; 16(5-6):405-10. PubMed ID: 6417731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte lithium transport during lithium treatment in patients with affective disorders.
    Zaremba D; Rybakowski J
    Pharmacopsychiatry; 1986 Mar; 19(2):63-7. PubMed ID: 3085111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).
    Nolen WA; Weisler RH
    Bipolar Disord; 2013 Feb; 15(1):100-9. PubMed ID: 23228201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interdependency of lithium ratio, plasma lithium level and clinical state in patients with affective disorders.
    Elizur A; Treves I
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):167-72. PubMed ID: 4001431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium ratio and hypertension in manic-depressive patients.
    McCoy SN; Thavundayil JX; Schwartz G; Etienne P
    Am J Psychiatry; 1982 Feb; 139(2):247-8. PubMed ID: 6798887
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced cell membrane affinity for lithium ion during maintenance treatment of bipolar affective disorder.
    Mallinger AG; Himmelhoch JM; Thase ME; Dippold C; Knopf S
    Biol Psychiatry; 1990 Apr; 27(7):795-8. PubMed ID: 2109641
    [No Abstract]   [Full Text] [Related]  

  • 9. Lithium maintenance: factors affecting outcome.
    Kocsis JH; Stokes PE
    Am J Psychiatry; 1979 Apr; 136(4B):563-6. PubMed ID: 426144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of plasma to erythrocyte lithium levels in patients taking lithium carbonate.
    Lee CR; Hill SE; Dimitrakoudi M; Jenner FA; Pollitt RJ
    Br J Psychiatry; 1975 Dec; 127():596-8. PubMed ID: 1201455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte glycine in depressed, hypomanic, and euthymic bipolar patients treated with lithium carbonate.
    Peselow ED; Deutsch SI; Stanley M; Banay-Schwartz M; Virgilio J; Fieve RR
    Psychopharmacology (Berl); 1982; 78(4):314-6. PubMed ID: 6818590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium accumulation in erythrocytes of manic-depressive patients: an in vivo twin study.
    Mendlewicz J; Verbanck P; Linkowski P; Wilmotte J
    Br J Psychiatry; 1978 Nov; 133():436-44. PubMed ID: 569523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium distribution in mania: plasma and red blood cell lithium, clinical state, and monoamine metabolites during lithium treatment.
    Swann AC; Berman N; Frazer A; Koslow SH; Secunda S
    Psychiatry Res; 1987 Jan; 20(1):1-12. PubMed ID: 2882535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis.
    Coppen A; Abou-Saleh M; Milln P; Bailey J; Wood K
    J Affect Disord; 1983 Nov; 5(4):353-62. PubMed ID: 6229567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening and evaluation on predictive factors in lithium carbonate maintenance treatment of manic-depressive disorders].
    Jiang ZN
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Dec; 23(6):324-8, 383. PubMed ID: 1982995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of the lithium erythrocyte: plasma ratio to plasma lithium level.
    Schreiner HC; Dunner DL; Meltzer HL; Fieve RR
    Biol Psychiatry; 1979 Feb; 14(1):207-13. PubMed ID: 420901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell membrane predictors of response to lithium prophylaxis of affective disorders.
    Del Vecchio M; Farzati B; Maj M; Minucci P; Guida L; Kemali D
    Neuropsychobiology; 1981; 7(5):243-7. PubMed ID: 7312143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and erythrocyte magnesium levels in patients with primary affective disorder during chronic lithium treatment.
    Dunner DL; Meltzer HL; Schreiner HC; Feigelson JL
    Acta Psychiatr Scand; 1975 Feb; 51(2):104-9. PubMed ID: 1091123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of erythrocyte glycine levels during lithium treatment of affective disorders.
    Rosenblatt S; Leighton WP; Chanley JD
    Psychiatry Res; 1982 Apr; 6(2):203-14. PubMed ID: 6953459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.